Honest Company Inc vs Moderna, Inc. — how do they compare? Honest Company Inc trades at $3.88 (market cap $426.55M), while Moderna, Inc. trades at $59.72 (market cap $23.60B). The key difference: Moderna, Inc. is far larger — about 55.3× Honest Company Inc's market cap. Which is the better fit depends on your goals.
| HNST | MRNA | |
|---|---|---|
Market Cap | $426.55M | $23.60B |
Sector | Consumer Staples | Health |
52-Week High | $4.95 | $81.80 |
52-Week Low | $2.10 | $22.36 |
Enterprise Value | $347.95M | $19.70B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Moderna (MRNA) trades at $59.66, down 3.49% in the last session amid broader biotech volatility. The stock shows a mixed technical picture with bullish overall signals but bearish moving averages. Fundamentally, revenue has declined from pandemic peaks to $1.92B in 2025, with net losses widening to -$2.82B. Recent positive developments include an EU RSV vaccine contract and progress in cancer immunotherapy trials, with Q2 2026 earnings due July 31.
Outlook remains speculative as Moderna transitions beyond COVID-19 vaccines. Opportunities lie in its expanding pipeline in oncology and flu vaccines, but risks include sustained losses, competitive pressure, and execution hurdles. Analyst consensus is cautious with a $49 price target below current levels, reflecting uncertainty over profitability timeline.
Trailing returns across standard periods
Latest headlines on both assets
The Honest Co Inc is a consumer products company. It offers eco-friendly diapers and a natural line of bath, skincare, home cleaning, and organic nutritional supplement products and other products.
Read more on HNST →Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →